secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOADAPTIVES, INC. (BDPT)
CIK:        0001575142
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001640334-24-001612
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAdaptives plans reverse stock split after shares balloon 6,530% in 5 years; CEO cites turnaround
--------------------------------------------------------------------------------

- Shares outstanding grew from 18.6M (Jan 2020) to 1.23B (June 2024), a 6,530% increase with no revenue growth.
- Reverse split intended to lift stock from sub-penny range; ratio and effective date not yet specified.
- CEO James Keener (since management change) leading turnaround with new product lines for human and animal health.
- Company expects increased revenue and profitability from upcoming product launches through new distribution channels.
- Draft letter prematurely published by website contractor error; this press release clarifies the planned reverse split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1575142/000164033424001612/0001640334-24-001612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1575142/000164033424001612/bdpt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-001612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer